Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients

计划入组 300 人 · 首次发布于 2021 年 2 月 15 日

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

计划入组 2,000 人 · 首次发布于 2024 年 3 月 7 日

Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis

计划入组 80 人 · 首次发布于 2025 年 3 月 10 日

PSC-01

trimethylangelicin (Rare Partners)

PSC-1721

THE ARAB PHARMACEUTICAL MANUFACTURING PSC

Jordan

Trillium Health Partners

Canada

New Leaf Partners

United States

VCU Joins Global Initiative to Accelerate Drug Development for Primary Sclerosing Cholangitis

Mirum Pharmaceuticals Completes Enrollment in Phase 2b VISTAS Study for Primary Sclerosing Cholangitis Treatment

Vancomycin Shows Promise in Treating PSC-Associated Inflammatory Bowel Disease